Leniobio
1 known investors
LenioBio develops ALiCE, a cell-free protein expression system derived from eukaryotic cells that produces full-length, folded, and functional proteins, including membrane proteins, without living cell culture. It targets research and biopharma lab teams needing fast protein screening and production, with reactions scalable from screening to multi-liter volumes.
AI & Machine LearningBiotechDeep Tech
Investors Β· 1
Frequently asked questions
- What does Leniobio do?
- LenioBio develops ALiCE, a cell-free protein expression system derived from eukaryotic cells that produces full-length, folded, and functional proteins, including membrane proteins, without living cell culture. It targets research and biopharma lab teams needing fast protein screening and production, with reactions scalable from screening to multi-liter volumes.
- Who are Leniobio's investors?
- Leniobio's investors include Bridford Investments (Bridford Group).